Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab

BACKGROUND: Dual human epidermal growth factor receptor 2 (HER2) blockade with trastuzumab and pertuzumab (TP) is a standard therapy of metastatic and localized HER2-positive breast cancer (BC), but its activity in breast cancer brain metastases (BCBM) is unknown. METHODS: Patients with HER2-positiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergen, Elisabeth Sophie, Binter, Amelie, Starzer, Angelika Martina, Heller, Gerwin, Kiesel, Barbara, Tendl-Schulz, Kristina, Bago-Horvath, Zsuzsanna, Furtner, Julia, Leitner, Johannes, Exner, Ruth, Fitzal, Florian, Dieckmann, Karin, Widhalm, Georg, Preusser, Matthias, Berghoff, Anna Sophie, Bartsch, Rupert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072867/
https://www.ncbi.nlm.nih.gov/pubmed/33995593
http://dx.doi.org/10.1177/17588359211009002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072867/
https://www.ncbi.nlm.nih.gov/pubmed/33995593
http://dx.doi.org/10.1177/17588359211009002

Ejemplares similares